BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28412739)

  • 1. Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma.
    Wang X; Dasari S; Nowakowski GS; Lazaridis KN; Wieben ED; Kadin ME; Feldman AL; Boddicker RL
    Oncotarget; 2017 Apr; 8(16):26245-26255. PubMed ID: 28412739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.
    Wilcken NR; Sarcevic B; Musgrove EA; Sutherland RL
    Cell Growth Differ; 1996 Jan; 7(1):65-74. PubMed ID: 8788034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
    Peng X; Yun D; Christov K
    Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells.
    Hosokawa Y; Yang M; Kaneko S; Tanaka M; Nakashima K
    Biochem Mol Biol Int; 1995 Oct; 37(2):393-9. PubMed ID: 8673024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha.
    Wang J; Barsky LW; Shum CH; Jong A; Weinberg KI; Collins SJ; Triche TJ; Wu L
    J Biol Chem; 2002 Nov; 277(45):43369-76. PubMed ID: 12213824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers.
    Alsafadi S; Even C; Falet C; Goubar A; Commo F; Scott V; Quidville V; Albiges L; Dieci MV; Guegan J; Lazar V; Ahomadegbe JC; Delaloge S; André F
    Clin Breast Cancer; 2013 Oct; 13(5):401-8. PubMed ID: 23830798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-phase arrest and apoptosis induced in normal mammary epithelial cells by a novel retinoid.
    Zhang Y; Rishi AK; Dawson MI; Tschang R; Farhana L; Boyanapalli M; Reichert U; Shroot B; Van Buren EC; Fontana JA
    Cancer Res; 2000 Apr; 60(7):2025-32. PubMed ID: 10766194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of protein expression, growth and apoptosis by natural and synthetic retinoids.
    Pratt MA; Niu M; White D
    J Cell Biochem; 2003 Nov; 90(4):692-708. PubMed ID: 14587026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid modulates a bimodal effect on cell cycle progression in human adult T-cell leukemia cells.
    Dierov J; Sawaya BE; Prosniak M; Gartenhaus RB
    Clin Cancer Res; 1999 Sep; 5(9):2540-7. PubMed ID: 10499631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
    Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of retinoic acid receptor-alpha is directly regulated at its protein kinase A sites in response to follicle-stimulating hormone signaling.
    Santos NC; Kim KH
    Endocrinology; 2010 May; 151(5):2361-72. PubMed ID: 20215566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fate.
    Rossetti S; Ren M; Visconti N; Corlazzoli F; Gagliostro V; Somenzi G; Yao J; Sun Y; Sacchi N
    Oncotarget; 2016 Dec; 7(52):87064-87080. PubMed ID: 27894085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition.
    Afonja O; Raaka BM; Huang A; Das S; Zhao X; Helmer E; Juste D; Samuels HH
    Oncogene; 2002 Nov; 21(51):7850-60. PubMed ID: 12420222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
    Zou C; Liebert M; Zou C; Grossman HB; Lotan R
    J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.
    Paroni G; Fratelli M; Gardini G; Bassano C; Flora M; Zanetti A; Guarnaccia V; Ubezio P; Centritto F; Terao M; Garattini E
    Oncogene; 2012 Jul; 31(29):3431-43. PubMed ID: 22056878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.
    Chen Q; Ross AC
    Exp Cell Res; 2004 Jul; 297(1):68-81. PubMed ID: 15194426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.
    McKeown MR; Corces MR; Eaton ML; Fiore C; Lee E; Lopez JT; Chen MW; Smith D; Chan SM; Koenig JL; Austgen K; Guenther MG; Orlando DA; Lovén J; Fritz CC; Majeti R
    Cancer Discov; 2017 Oct; 7(10):1136-1153. PubMed ID: 28729405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.